196 related articles for article (PubMed ID: 35265719)
1. Clinical Significance of OX40 and OX40 Ligand in the Peripheral Blood of Patients with Myasthenia Gravis.
Zhou X; Wang X; Gu Y; Chen L; Shen Y; Tian J; Shujun C; Wang M; Duan X; Gao H; Ji X; Fang Q; Zhang X; Xue Q
J Immunol Res; 2022; 2022():4337399. PubMed ID: 35265719
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of the Soluble Form of OX40 and OX40L Costimulatory Molecules but Reduction of the Membrane Form in Type 1 Diabetes (T1D).
An J; Ding S; Li S; Sun L; Chang X; Huang Z; Zhou B; Fang C; Liu C; Zhang X
J Immunol Res; 2019; 2019():1780567. PubMed ID: 31467932
[TBL] [Abstract][Full Text] [Related]
3. Soluble OX40L is associated with presence of autoantibodies in early rheumatoid arthritis.
Laustsen JK; Rasmussen TK; Stengaard-Pedersen K; Hørslev-Petersen K; Hetland ML; Østergaard M; Junker P; Hvid M; Deleuran B
Arthritis Res Ther; 2014 Oct; 16(5):474. PubMed ID: 25359291
[TBL] [Abstract][Full Text] [Related]
4. Increased Expressions of OX40 and OX40 Ligand in Patients with Primary Immune Thrombocytopenia.
Cui D; Lv Y; Yuan X; Ruan G; Zhang Y; Yan C; Xu D; Lv M; Mao Y; Cao J; Jin J; Xie J
J Immunol Res; 2019; 2019():6804806. PubMed ID: 30944836
[TBL] [Abstract][Full Text] [Related]
5. [Expressions and clinical significance of OX40 and OX40L in peripheral blood of patients with primary Sjogren's syndrome].
Zhu R; Jiang J; Wang T; Xu T; Wu M; Liu C; Zhang X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Aug; 29(8):862-5. PubMed ID: 23948416
[TBL] [Abstract][Full Text] [Related]
6. High blood levels of soluble OX40 (CD134), an immune costimulatory molecule, indicate reduced survival in patients with advanced colorectal cancer.
Sawada R; Arai Y; Sagawa Y; Nagata Y; Nishimura T; Noguchi M; Amano K; Arihiro S; Saruta M; Homma S
Oncol Rep; 2019 Nov; 42(5):2057-2064. PubMed ID: 31545443
[TBL] [Abstract][Full Text] [Related]
7. Expression of OX40 and OX40 ligand (gp34) in the normal and myasthenic thymus.
Onodera J; Nagata T; Fujihara K; Ohuchi M; Ishii N; Sugamura K; Itoyama Y
Acta Neurol Scand; 2000 Oct; 102(4):236-43. PubMed ID: 11071109
[TBL] [Abstract][Full Text] [Related]
8. The OX40 Axis is Associated with Both Systemic and Local Involvement in Atopic Dermatitis.
Elsner JS; Carlsson M; Stougaard JK; Nygaard U; Buchner M; Fölster-Holst R; Hvid M; Vestergaard C; Deleuran M; Deleuran B
Acta Derm Venereol; 2020 Mar; 100(6):adv00099. PubMed ID: 32176307
[TBL] [Abstract][Full Text] [Related]
9. Positive correlation between pregnancy-associated plasma protein-A level and OX40 ligand expression in patients with acute coronary syndromes.
Liu P; Yan J; Gong J; Wang C; Chen G
Biomed Pharmacother; 2011 Jun; 65(3):193-7. PubMed ID: 21111564
[TBL] [Abstract][Full Text] [Related]
10. Increased OX40 and soluble OX40 ligands in children with Henoch-Schonlein purpura: association with renal involvement.
Qin W; Hongya W; Yongjing C; Fang X; Yue M; Xuekun Z; Xiaozhong L; Xueguang Z
Pediatr Allergy Immunol; 2011 Feb; 22(1 Pt 1):54-9. PubMed ID: 21143648
[TBL] [Abstract][Full Text] [Related]
11. OX40/OX40L in systemic lupus erythematosus: association with disease activity and lupus nephritis.
Farres MN; Al-Zifzaf DS; Aly AA; Abd Raboh NM
Ann Saudi Med; 2011; 31(1):29-34. PubMed ID: 21245596
[TBL] [Abstract][Full Text] [Related]
12. Association of high levels of plasma OX40 with acute adult T-cell leukemia.
Tanaka Y; Takahashi Y; Tanaka R; Miyagi T; Saito M; Fukushima T
Int J Hematol; 2019 Mar; 109(3):319-327. PubMed ID: 30652238
[TBL] [Abstract][Full Text] [Related]
13. The clinical implications of increased OX40 ligand expression in patients with acute coronary syndrome.
Liu DM; Yan JC; Wang CP; Chen GH; Ding S; Liu PJ; Du RZ
Clin Chim Acta; 2008 Nov; 397(1-2):22-6. PubMed ID: 18674525
[TBL] [Abstract][Full Text] [Related]
14. Requirements for the functional expression of OX40 ligand on human activated CD4+ and CD8+ T cells.
Kondo K; Okuma K; Tanaka R; Zhang LF; Kodama A; Takahashi Y; Yamamoto N; Ansari AA; Tanaka Y
Hum Immunol; 2007 Jul; 68(7):563-71. PubMed ID: 17584577
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of OX40-OX40 ligand system on T lymphocytes in patients with acute coronary syndromes.
Yan J; Chen G; Gong J; Wang C; Du R
J Cardiovasc Pharmacol; 2009 Nov; 54(5):451-5. PubMed ID: 19738490
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of CD4(+) T cell response and survival via coexpressed OX40/OX40L in Graves' disease.
Wang Q; Shi BM; Xie F; Fu ZY; Chen YJ; An JN; Ma Y; Liu CP; Zhang XK; Zhang XG
Mol Cell Endocrinol; 2016 Jul; 430():115-24. PubMed ID: 27107937
[TBL] [Abstract][Full Text] [Related]
17. Preparation, characterization and application of anti-human OX40 ligand (OX40L) monoclonal antibodies and establishment of a sandwich ELISA for autoimmune diseases detection.
An J; Ding S; Hu X; Sun L; Gu Y; Xu Y; Hu Y; Liu C; Zhang X
Int Immunopharmacol; 2019 Feb; 67():260-267. PubMed ID: 30562687
[TBL] [Abstract][Full Text] [Related]
18. Affinity and kinetics of the interaction between soluble trimeric OX40 ligand, a member of the tumor necrosis factor superfamily, and its receptor OX40 on activated T cells.
Al-Shamkhani A; Mallett S; Brown MH; James W; Barclay AN
J Biol Chem; 1997 Feb; 272(8):5275-82. PubMed ID: 9030600
[TBL] [Abstract][Full Text] [Related]
19. High soluble OX40 levels correlate with metastatic gastric cancer.
Lima CAC; Martins MR; Dos Santos RL; da Silva LM; Silva JPA; Torres LC; Forones NM
J Surg Oncol; 2022 Jul; 126(1):139-143. PubMed ID: 35689573
[TBL] [Abstract][Full Text] [Related]
20. High Serum OX40 and OX40 Ligand (OX40L) Levels Correlate with Reduced Survival in Patients with Advanced Lung Adenocarcinoma.
Kashima J; Okuma Y; Hosomi Y; Hishima T
Oncology; 2020; 98(5):303-310. PubMed ID: 32097938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
